BREAKING
National

Centre Proposes Separate Licensing Rules For Wholesale Trade Of Bulk Drugs

The Centre has suggested a special licensing system for bulk drugs wholesale trading in order to enhance the regulatory mechanism and accountability along the pharmaceutical supply chain.

Changes in the Drugs Rules, 1945, have been proposed by the Ministry of Health and Family Welfare, which will have to provide separate application and licence forms for companies that engage in wholesale activities of bulk drugs (active and inactive).

The proposed changes will have the applicant making an application for a licence on Form 19-BC with the licence to be issued on Form 20-BC. These will be different from the current licensing requirements for pharmaceutical formulations.

At present, there is a common licence available for wholesale trading of bulk drugs and formulations. The proposed framework is designed to implement a separate licensing regime for the wholesale of bulk drugs to permit a more targeted approach to regulatory oversight.

The ministry has said the changes are designed to improve the supervision and make it more accountable to distribute bulk drugs.

The Drugs Consultative Committee (DCC) approved the proposal on 17th November 2025 at its meeting held on 67th. This was later agreed at the 93rd meeting of Drugs Technical Advisory Board (DTAB) on 16th February 2026.

The ministry has also said it will provide licence holders with adequate notice to comply with the new requirements, thereby ensuring a seamless transition to a new licensing system.